Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Priya Life Science Clinical trial register
Trackers› Clinical trials› Heart Failure
Clinical trial register · Australia

Heart Failure Trials in Australia, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Australia and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 3370 matching records held by the registry are in this view. Synced 11 Nov 2026, 03:19 UTC
3370
Studies in scope
all four open statuses
1816
Recruiting now
open to new participants
776
Lead sponsors
across recruiting studies
Top sites
Melbourne 8 Chermside 8 Adelaide 8 Brisbane 6 New Lambton Heights 5

Heart Failure trials in Australia

25 of 3370 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Australia
Start
Recruiting
Novo Nordisk A/S
Phase 3
5,610
Canberra, Liverpool, Chelmer, Chermside, Ipswich, Milton, Adelaide, Bedford Park
2026-05-11
Recruiting
Pacing Advancements With Cost and Experience VALuation for Unified Patient-Led Clinical Evidence - the PACEVALUE Study
NCT07276139Cardiomyopathy, Secondary, Arrhythmias, Cardiac, Heart Failure, Pacing Induced Cardiomyopathy
Insel Gruppe AG, University Hospital Bern
Observational
4,500
Canberra
2026-01-01
Recruiting
EBR Systems, Inc.
Not applicable
40
Birtinya, Herston, Southport, Woolloongabba
2025-12-18
Active, closed
Biotronik Australia Pty Ltd.
Not applicable
52
Brisbane
2025-07-23
Recruiting
Novo Nordisk A/S
Phase 2
200
Concord, Brisbane, Adelaide, Bedford Park, Hobart, Clayton, Murdoch
2025-06-30
Active, closed
ASCEND CSP IDE Study
NCT06830746Heart Failure, Ventricular Arrythmia
Abbott Medical Devices
Not applicable
414
Chermside, Woolloongabba, Adelaide, Clayton
2025-04-11
Recruiting
AstraZeneca
Phase 3
11,300
Adelaide, Castle Hill, Coffs Harbour, Elizabeth Vale, Fremantle, Geelong, Kingswood, Leabrook
2025-03-14
Recruiting
Alleviant ALLAY-HFrEF Study
NCT06812533Heart Failure
Alleviant Medical, Inc.
Not applicable
350
Clayton, Melbourne
2025-03-10
Recruiting
Boehringer Ingelheim
Phase 3
6,712
Garran, Concord, Gosford, Kingswood, Kotara, Brisbane, Chermside, Tugun
2024-06-17
Active, closed
Novo Nordisk A/S
Phase 3
673
Garran, New Lambton Heights, Wollongong, Brisbane, Chermside, Ballarat, Epping, Mulgrave
2024-04-01
Recruiting
The STOP-MED CTRCD Trial
NCT06183437Heart Failure, Cardiotoxicity, Cardiac Toxicity, Antineoplastics Toxicity
Dinesh Thavendiranathan
Phase 4
335
Melbourne
2024-03-04
Recruiting
Colorado Prevention Center
Phase 3
5,200
Blacktown, Milton, Elizabeth Vale, Melbourne, Mulgrave, Adelaide
2024-01-17
Recruiting
Baker Heart and Diabetes Institute
Not applicable
685
Melbourne
2023-03-30
Recruiting
Baker Heart and Diabetes Institute
Not applicable
612
Alice Springs
2023-02-24
Recruiting
Alleviant ALLAY-HF Study
NCT05685303Heart Failure
Alleviant Medical, Inc.
Not applicable
700
Clayton, Heidelberg
2023-01-10
Active, closed
RESPONDER-HF Trial
NCT05425459Heart Failure, Heart Failure, Diastolic
Corvia Medical
Not applicable
750
Darlinghurst, New Lambton Heights, Chermside, Melbourne
2022-11-17
Active, closed
University Medical Center Groningen
Phase 3
1,750
Canberra, New Lambton Heights, Sydney, Wollongong, Birtinya, Brisbane, Douglas, Adelaide
2022-11-08
Recruiting
Baker Heart and Diabetes Institute
Not applicable
820
Melbourne
2021-11-18
Active, closed
Statins in Reducing Events in the Elderly (STAREE) Heart Sub-study
NCT04536870Heart Failure, Atrial Fibrillation, Healthy Ageing, Hypercholesterolemia
Monash University
Not applicable
369
Melbourne, Perth
2019-12-12
Active, closed
V-Wave Ltd
Not applicable
605
Darlinghurst, Adelaide, Brisbane, Melbourne
2018-09-19
Active, closed
Biotronik SE & Co. KG
Observational
3,030
Canberra, Elizabeth Vale, Liverpool, Sydney, Westmead
2018-05-14
Active, closed
PARTNER 3 Trial - Mitral Valve in Valve
NCT03193801Mitral Valve Insufficiency, Mitral Valve Disease, Mitral Valve Regurgitation, Heart Failure
Edwards Lifesciences
Not applicable
53
Chermside
2018-02-01
Active, closed
EBR Systems, Inc.
Not applicable
300
Garran, New Lambton Heights, Randwick, Wahroonga, Chermside, Adelaide, Clayton, Parkville
2018-01-17
Active, closed
REDUCE LAP-HFREF TRIAL
NCT03093961Heart Failure
Corvia Medical
Not applicable
10
New Lambton Heights, Sydney
2017-03-10
Recruiting
Medtronic
Observational
20,000
Chermside, Douglas, Murdoch, Southport
1983-01
Rows per page Showing 1–25 of 25
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Australian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 12 November 2026. https://priyalifescience.com/clinical-trials-australia/condition/heart-failure

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Australia and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 3,370 studies in total at the last sync on 11 Nov 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 25 of those studies listing the condition Heart Failure.

How many Heart Failure trials are recruiting in Australia?

14 of the 25 studies on this page are recruiting new participants as of the 11 Nov 2026, 03:19 UTC sync. A further 0 have not yet opened recruitment, 11 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Heart Failure), 25 studies
PhaseStudiesRecruitingShare
Not applicable14656%
Phase 36424%
Observational3212%
Phase 2114%
Phase 4114%

Most active sponsors

Lead sponsors with the most studies (Heart Failure)
Lead sponsorStudiesRecruiting
Baker Heart and Diabetes Institute33
Novo Nordisk A/S32
Alleviant Medical, Inc.22
Corvia Medical20
EBR Systems, Inc.21
Abbott Medical Devices10
AstraZeneca11
Biotronik Australia Pty Ltd.10
Biotronik SE & Co. KG10
Boehringer Ingelheim11
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.